Liyong Shi Lianshun Lin Yin Ding Yiming Zeng Xiaoyang Chen
10.3389/fonc.2022.1020875
Front Oncol
2022 Nov 1;12:1020875.
pd-l1 expression smarca4-ut immune checkpoint inhibitor immunotherapy tislelizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/36452500/
Case Reports
PMC9703460
36452500
Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure
2022